CABA Competitors & Alternatives
Compare Cabaletta Bio Inc with similar stocks in the same industry
Biotechnology
CABA
Main Stock$3.13
Tradestie Score
57
Market Cap
$211.28M
Analyst Upside
+327.3%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$16.08
|
$540.97M | - | 54 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.85
|
$533.99M | - | 54 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$14.75
|
$529.35M | 6.9 | 61 | Compare |
|
OCGN
Ocugen, Inc. Common Stock
|
$1.50
|
$524.67M | - | 58 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$99.27
|
$522.78M | - | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.27
|
$512.39M | - | 61 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$42.93
|
$505.12M | 2.1 | 61 | Compare |
|
RGNX
REGENXBIO Inc.
|
$15.23
|
$493.52M | - | 55 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$97.10
|
$492.21M | - | 54 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$45.00
|
$474.20M | 28.0 | 64 | Compare |
More CABA Analysis
Data updated: Jul 08, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry